![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/end-effector-therapeutics-oncology-biotech-winds-down-after-mid-stage-fail
https://www.globenewswire.com/news-release/2024/05/09/2879129/0/en/eFFECTOR-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/09/2859911/0/en/eFFECTOR-Therapeutics-to-Participate-in-Upcoming-Investor-Conference.html
https://endpts.com/effectors-lead-nsclc-program-falls-through-stock-crashes/
https://www.globenewswire.com/news-release/2024/03/25/2851978/0/en/eFFECTOR-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/02/05/2823517/0/en/eFFECTOR-Therapeutics-to-Present-at-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/01/29/2819427/0/en/eFFECTOR-Therapeutics-Announces-Closing-of-15-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2024/01/25/2816695/0/en/eFFECTOR-Therapeutics-Announces-15-Million-Registered-Direct-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2024/01/09/2806253/0/en/eFFECTOR-Therapeutics-to-Host-Virtual-Investor-R-D-Day-on-January-24-2024.html
https://www.globenewswire.com//news-release/2024/01/09/2806241/0/en/eFFECTOR-Therapeutics-Announces-Reverse-Stock-Split.html